Colcrys for Acute Gout Greensboro NC

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

Dr. James G Crawford
(336) 419-1329
107 N Murrow Blvd
Greensboro, NC

Data Provided by:
Daniel F Murphy, MD
(336) 375-2300
1130 N Church St
Greensboro, NC
Business
Murphy & Wainer Orthopaedics
Specialties
Orthopedics

Data Provided by:
Healing Hands Chiropractic
(336) 303-8980
1915 Lendew Street
Greensboro, NC

Data Provided by:
Crawford Chiropractic Center
(336) 450-2614
1109 Summit Ave
Greensboro, NC

Data Provided by:
Greensboro Veterinary Hospital
(336) 299-5431
3741 High Point Rd
Greensboro, NC

Data Provided by:
David M. Bowers
(336) 275-0919
300 W. Northwood Street
Greensboro, NC
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Happy Tails Veterinary Emergency Clinic
(336) 288-2688
2936 Battleground Ave
Greensboro, NC

Data Provided by:
Stephen A South, MD
(336) 621-8911
2703 Henry St
Greensboro, NC
Business
Guilford Medical Associates PA
Specialties
Endocrinology, Diabetes & Metabolism

Data Provided by:
Lawndale Veterinary Hospital
(336) 288-3233
4314 Lawndale Dr
Greensboro, NC

Data Provided by:
HealthSource of Greensboro West
(336) 289-9997
4518 W Market St
Greensboro, NC

Data Provided by:
Data Provided by:

Colcrys for Acute Gout

Provided By:

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

In a news release, the agency said colchicine has been used as a remedy to treat acute gout flares "for many years," despite that it hadn't been FDA approved. The agency said it was in the midst of a program to bring other similarly unapproved products under its regulatory authority.

A dosing study required for approval led the agency to recommend a lower dosing regimen for Colcrys that had been commonly prescribed, the news release said. This was designed to prevent gastrointestinal problems.

The FDA said it was alerting healthcare professionals of the lower dosing schedule and also warning that the drug had the potential for severe interactions with other medications.

FMF, common in Mediterranean nations but less so in the United States, has symptoms including fever, arthritis, and inflammation of the lining of the lungs and abdomen. Colcrys is now the first drug that's been FDA-approved to treat FMF, the agency said.

The drug is produced by Philadelphia-based Mutual Pharmaceutical Company Inc.

More information

The FDA has more about this medication's approval.

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com